FTC cows Sanofi into giving up on Maze licensing deal
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.
Source: mmm-online.com
Science Ecosystem News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Science Ecosystem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Science Ecosystem Today - Breaking & Trending Today
Antitrust & Competition Life Sciences Quarterly Update Q3 2023
The third quarter in the life sciences space saw notable developments in significant agency enforcement actions: The FTC abandoned its pursuit of a novel theory and settled its Amgen/Horizon lawsuit...
Source: marketscreener.com
Antitrust & Competition Life Sciences Quarterly Update - Q3 2023 | Goodwin
The FTC’s Amgen/Horizon Lawsuit Ends With a Whimper - We covered the FTC’s investigation into (and litigation challenging) Amgen’s $28.3 billion acquisition of rare...
Source: jdsupra.com
Pharma Giants Combine Forces to Fight New M&A Rules
Some of pharma's biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Source: thedailyupside.com
31 drugmakers, biotechs form pro-M&A group
More than two dozen life science, pharmaceutical and biotech organizations partner to form the Partnership for the U.S. Life Science Ecosystem (PULSE).
Source: beckershospitalreview.com